The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> October 23, 2015

Interview with the CEO and Chairman: Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX)

Kazimi, A.J.
A.J. Kazimi founded Cumberland Pharmaceuticals, Inc., in 1999 and has served as Chief Executive Officer and Chairman of the board of directors since its inception. Prior to forming Cumberland, he served as President and Chief Operating Officer of Therapeutic Antibodies Inc., a biopharmaceutical company. During his 11 years with the company, Mr. Kazimi oversaw operations in three countries and played a key role in the company’s product development strategies, licensing and distribution agreements, and the raising of more than $100 million through equity and debt financings, as well as its initial public offering. Earlier in his career, he worked at Brown-Forman Corporation, rising through a series of management positions. Mr. Kazimi previously served on the board of directors for the Nashville Health Care Council, an industry association representing the largest concentration of health care companies in the United States, and Aegis Toxicology Sciences Corporation, a federally certified forensic toxicology laboratory. He also serves as Chief Executive Officer of Cumberland Emerging Technologies, Inc. — CET. He holds a B.S. from the University of Notre Dame and an MBA from the Vanderbilt Owen Graduate School of Management. Profile
TWST: Could you provide a brief overview of your company and describe its business model if at all unique?

Mr. Kazimi: Cumberland is a specialty pharmaceutical

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy